Zacks.com on MSN1 天
GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli
GSK plc’s GSK HIV subsidiary, ViiV Healthcare announced that the Europe Medicines Agency’s (“EMA”) Committee for Medicinal ...
CHMP Endorses Merck's Kidney Cancer Drug for Two Indications
The CHMP's opinion is based on positive results from two late-stage studies on MRK's Welireg in two indications associated ...
Zacks.com on MSN5 天
NVO Gets Positive CHMP Opinion in EU for Ozempic Expanded Use in CKD
Novo Nordisk's diabetes drug, Ozempic, receives positive CHMP opinion in the EU for expanded use in T2D and CKD patients.
ophthalmologytimes2 天
EMA CHMP issues positive opinion for aflibercept biosimilar from Celltrion
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) announced opinions for three ...
Zacks.com on MSN2 天
GILD Obtains Positive CHMP Opinion for Liver Disease Drug
GILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) ...
PharmaTimes2 天
CSL receives positive opinion for garadacimab in hereditary angioedema
Global biotechnology leader CSL has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...
Pharmabiz2 天
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment ...
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment of transthyretin amyloid cardiomyopathy: Berlin Monday, December 16, 2024, 13:00 Hrs [I ...
Eli Lilly’s Omvoh recommended by CHMP for approval in EU
Eli Lilly (LLY) and Company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive ...
Lilly gets positive EU regulatory opinion for Omvoh for Crohn's
Eli Lilly (NYSE: LLY) has received a positive recommendation for approval from European regulators for its drug Omvoh in the ...